SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is surging as a community-driven movement that emphasizes organic growth and a 'diamond hand' holding strategy over traditional pump-and-dump tactics. Investors are actively discussing the project's potential to reach significant market milestones, frequently highlighting their dedication to the 'Mauler' brand as they await broader chart integration.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir shares are seeing high volatility as investors weigh a direct presidential endorsement against bearish pressure from notable short-sellers who argue the company's valuation is detached from fundamentals and threatened by emerging AI competitors. The community remains deeply divided, with some betting on a massive short squeeze and institutional accumulation while others warn that the stock is caught in a wider software sector correction.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense market activity and social media buzz driven by speculation around high-profile partnerships, upcoming festival events, and its role in a decentralized music-event ecosystem. The community is sharply divided, with enthusiasts highlighting aggressive accumulation and technical breakout potential, while critics dismiss the asset as a volatile pump-and-dump scheme.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is currently trending due to intense market speculation surrounding its proprietary Perkinamine polymer technology and its integration into major silicon photonics foundries like Tower Semiconductor and GlobalFoundries. The community is actively debating the stock's potential as a critical AI infrastructure play versus concerns about its pre-revenue status and history of insider selling, with many investors closely watching for signs of commercial volume production to justify the company's valuation.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon & Co. is currently trending following an internal probe into sales practices that led to the resignation of its CEO, triggering significant volatility and investor concern regarding the company's future governance and financial outlook. While some market participants are wary of the audit findings, others are actively debating whether this sell-off presents a deep-value opportunity given the company's debt reduction efforts and core product portfolio.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is surging to all-time highs as investors pile into the stock ahead of its upcoming Nasdaq-100 index inclusion. The community is intensely debating whether this rapid, AI-driven rallywhich has seen the stock climb over 2,000% in a yearis a sustainable shift in market leadership or an overextended bubble nearing a potential reversal.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate the impact of AI agent competition against the company's strong fundamentals and established enterprise role. While the community remains polarized by recent volatility and technical support levels, many are focused on the potential for strategic shifts or buybacks to challenge the prevailing short interest.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is actively trending as community members highlight its unique status as a permissionless brand that encourages participants to build real-world products and businesses. Supporters are heavily focused on the project's long-term conviction, steady development of diverse initiatives, and its expanding multi-chain ecosystem.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently trending as investors weigh potential federal trust bank regulatory breakthroughs against ongoing macro volatility and sector-specific downgrades. The community remains sharply divided, with bulls pointing to long-term institutional adoption and pending legislative clarity, while bears focus on declining trading volumes and technical price weakness.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is drawing significant attention from investors as it navigates a volatile landscape marked by high-profile contracts, including security for the 2026 FIFA World Cup and major border demining projects. While community members are polarized over the stock's futurebalancing excitement for its aggressive expansion and defense tech partnerships against concerns regarding share dilution and persistent short-seller activitythe stock remains a central topic for those monitoring drone and autonomous systems within the broader defense sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UNH Stock Slides Pre-Market: United Health Warns Of Softer FY26 As Medicare Pressures Mount 

UnitedHealth expects revenue in 2026 of around $439 billion, a 2% year-over-year decline.

Equity

Be Thankful to These ETFs This Year 

Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.

Shares of Leap Therapeutics, Inc. nosedived more than 70% to an all-time low on Tuesday, making them the top loser across U.S. exchanges.The sharp drop — Leap’s worst intraday fall ever — came after the biotech firm announced it would terminate further development of sirexatamab in gastric cancer trials while shifting its focus to colorectal cancer (CRC).Leap reported data from the Phase 2 DeFianCe trial, which evaluated sirexatamab in combination with bevacizumab (Avastin) and chemotherapy for CRC.&nbsp;The trial showed an objective response rate (ORR) of 35% and a disease control rate (DCR) of 86%, slightly outperforming the control group (ORR: 23%, DCR: 84%). Preparations are now underway for a Phase 3 study targeting second-line CRC patients.However, results from the DisTinGuish study for gastric and gastroesophageal junction (GEJ) cancers were less promising.&nbsp;While sirexatamab combined with tislelizumab (BeiGene’s anti-PD-1 antibody) and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival (PFS) endpoints.Chief Medical Officer Cynthia Sirard cited challenges in radiological assessments and high discordance between investigator assessments and blinded independent central review (BICR) as reasons for the trial’s disappointing outcome.“Therefore, we have decided to focus our internal effort and resources on advancing sirexatamab in CRC and will explore strategic partnership opportunities to advance sirexatamab plus anti-PD-1 antibodies in gastric cancer and other indications where there is high DKK1 expression,” she said.Despite the stock’s dramatic plunge, retail chatter on Stocktwits revealed optimism about the CRC pipeline, with several hoping for a potential turnaround as Phase 3 trials progress.<stembedurl>https://stocktwits.com/inphatec1/message/601848582</stembedurl><stembedurl>https://stocktwits.com/Walter100/message/601825571</stembedurl>Leap ended the third quarter of 2024 with $62.8 million in cash, which it believes&nbsp;is sufficient to fund operations into the second quarter of 2026.The stock has lost over 72% in the past 12 months, including a 7.8% year-to-date decline before this session.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline

While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival endpoints.

PINK
Simplify Exchange Traded Funds - Simplify Health Care ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest PINK News

PINKSimplify Exchange Traded Funds - Simplify Health Care ETF